Royal Agrifirm Group completes acquisition of Hamlet Protein

01 May 2026

Apeldoorn, The Netherlands, 1 May 2026 – Royal Agrifirm Group today announces the successful completion of its acquisition of Hamlet Protein, a global leader in specialty soy‑based protein ingredients for young animal nutrition.

With the transaction now closed, Hamlet Protein becomes part of Royal Agrifirm Group’s Specialties business. The acquisition further strengthens Agrifirm’s portfolio of high-value nutritional solutions and its strategic focus on early-life nutrition.

Bas van Driel, Group Director Specialties at Royal Agrifirm Group, commented: “With the transaction now completed, we are pleased to welcome Hamlet Protein to our company. This step strengthens our Specialties business and our ability to support our valued customers with differentiated, science-based nutritional solutions.”

Hamlet Protein is internationally recognized for its highly digestible soy-based ingredients that support gut health and consistent early-life performance. Its patented processing technology and strong quality standards complement Royal Agrifirm Group’s nutritional expertise, scientific capabilities, and global market presence.

This may interest you as well

31 Mar 2026

Royal Agrifirm Group acquires Hamlet Protein, strengthening its global Specialties business

Apeldoorn, The Netherlands, 31 March 2026 – Royal Agrifirm Group has reached an agreement to acquire Hamlet Protein, a global leader in specialty soy-based protein ingredients for young animal nutrition. The transaction is expected to close in the coming weeks, subject to customary conditions.